Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified antibodies containing modified IGG2 domains which elicit agonist or antagonistic properties and use thereof

Modified antibodies containing modified IGG2 domains which elicit agonist or antagonistic properties and use thereof

US Patent 11059898 · Granted Jul 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer and B-cell related disease therapy2025
Immunomodulatory antibodies2023
Combined use of FcγRIIb (CD32B) and CD20 specific antibodies2023
Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibody2022
Immunomodulatory antibodies2021
Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies2020
Human immune therapies using a CD27 agonist in combination with another immune a2018
Human immune therapies using a CD27 agonist alone or in combination with other i2016
Human monoclonal antibodies against CD202013
Human immune therapies using a CD27 agonist alone or in combination with other i2013
Human monoclonal antibodies against CD202010